Vascular Medicine· 2026Q2
Torasik Aortik Tromboz: Klinik Özellikler, Sunum ve Sonuçlar
Clinical characteristics, presentation, and outcomes in patients with thoracic aortic thrombus
- 1atıf
- Q2SCImago
- 2026yıl
Kısa özet
Torasik aortik tromboz (TAT), arteriyel tromboembolizmin (ATE) nadir bir nedenidir; genç hastalar (<65 yaş) ve aortik arkta veya aterosklerotik/anevrizmatik olmayan nedenlerden kaynaklanan trombozlar en yüksek ATE riskini göstermektedir (OR 7.9-32.1).
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Torasik aortik tromboz (TAT) hastalarının %25'i arteriyel tromboembolizm (ATE) ile başvurdu.
- Genç yaş (<65 yaş), TAT hastalarında ATE için önemli bir risk faktörüdür (OR 7.9).
- Tromboz yeri (ark tutulumu, OR 3.7) ve etiyolojisi (ateroskleroz, OR 11.2; anevrizmatik/aterosklerotik olmayan, OR 32.1) ATE ile ilişkilidir.
- Anevrizmatik/aterosklerotik olmayan TAT hastaları daha yüksek oranda antikoagülasyon tedavisi aldı ve tromboz regresyonu gösterdi (%68'e karşılık %20).
- Ortalama 763 günlük takip süresince tekrarlayan spontan embolik olaylar nadirdi (149 hastada 3).
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
Background: Thoracic aortic thrombosis (TAT) is a rare, but important cause of arterial thromboembolism (ATE). There is a paucity of published data on TAT; therefore, risk stratification and management are challenging. In this study, we evaluated risk factors, presentation, and outcomes of patients diagnosed with TAT. Methods: In this retrospective analysis, we analyzed data on all patients diagnosed with TAT by computed tomographic angiography between 2013 and 2024 at a single tertiary care center. Results: A total of 149 patients with an average age of 69.6 years (IQR 60.1–77.1) and 45.0% men were included. The most proximal thrombus location was the ascending aorta, arch, and descending aorta in 20.8%, 19.5%, and 59.7% of patients, respectively. Thrombus was attributed to atherosclerosis in 28.2% of patients, aneurysm in 32.9%, and other/unknown etiologies for the remainder of the cohort. Approximately 25% of patients presented with ATE. In a multivariable analysis, risk factors associated with ATE included age < 65 years (OR 7.9, p < 0.01), arch involvement (OR 3.7, p = 0.04), thrombus associated with atherosclerosis (OR 11.2, p = 0.042), and thrombus in nonaneurysmal/nonatherosclerotic aortas (OR 32.1, p < 0.01) in patients with CT-detected aortic thrombus. Patients with aneurysmal or atherosclerotic etiologies were less likely to be managed with anticoagulation (16% vs 61%, p < 0.01) and less likely to show thrombus regression or resolution (20% vs 68%, p < 0.01). Recurrent spontaneous embolic events occurred in three of 149 patients (median follow-up of 763 days; IQR 364–1559). Conclusions: A significant proportion of patients with thoracic aortic thrombus present with ATE. Younger patients with arch thrombosis from nonaneurysmal/nonatherosclerotic etiologies are at the highest risk of ATE. Patients with nonaneurysmal/nonatherosclerotic etiologies of aortic thrombus were more likely to be treated with anticoagulation and show thrombus regression/resolution; however, the rate of recurrent spontaneous embolic events was low.
Yazarların özeti; kaynağından alınmıştır. Vascular Medicine, 2026 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Göğüs ve Solunum Tıbbı
Pulmonary and Respiratory MedicineMedicine